C19orf66 Inhibits Japanese Encephalitis Virus Replication by Targeting -1 PRF and the NS3 Protein
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C19orf66 Inhibits Japanese Encephalitis Virus Replication by Targeting -1 PRF and the NS3 Protein
Authors
Keywords
-
Journal
VIROLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-26
DOI
10.1007/s12250-021-00423-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Japanese Encephalitis Virus NS1′ Protein Inhibits Type I IFN Production by Targeting MAVS
- (2020) Dengyuan Zhou et al. JOURNAL OF IMMUNOLOGY
- C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelle
- (2020) Volker Kinast et al. JOURNAL OF HEPATOLOGY
- C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3
- (2020) Yun Wu et al. PLoS Neglected Tropical Diseases
- Regulation of HIV-1 Gag-Pol Expression by Shiftless, an Inhibitor of Programmed -1 Ribosomal Frameshifting
- (2019) Xinlu Wang et al. CELL
- C19ORF66 Broadly Escapes Virus-Induced Endonuclease Cleavage and Restricts Kaposi’s Sarcoma-Associated Herpesvirus
- (2019) William Rodriguez et al. JOURNAL OF VIROLOGY
- Comparison of the live-attenuated Japanese encephalitis vaccine SA14 -14-2 strain with its pre-attenuated virulent parent SA14 strain: similarities and differences in vitro and in vivo
- (2016) Sang-Im Yun et al. JOURNAL OF GENERAL VIROLOGY
- IRAV ( FLJ11286 ), an Interferon-Stimulated Gene with Antiviral Activity against Dengue Virus, Interacts with MOV10
- (2016) Corey A. Balinsky et al. JOURNAL OF VIROLOGY
- Flavivirus NS1: a multifaceted enigmatic viral protein
- (2016) Meghana Rastogi et al. Virology Journal
- Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication
- (2016) Youichi Suzuki et al. PLoS Pathogens
- The A66G back mutation in NS2A of JEV SA 14 -14-2 strain contributes to production of NS1′ protein and the secreted NS1′ can be used for diagnostic biomarker for virulent virus infection
- (2015) Jingman Wang et al. INFECTION GENETICS AND EVOLUTION
- Porcine 2′, 5′-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro
- (2015) Sheng Zheng et al. JOURNAL OF MEDICAL VIROLOGY
- Japanese encephalitis
- (2015) K. MORITA et al. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- Changed in translation: mRNA recoding by −1 programmed ribosomal frameshifting
- (2015) Neva Caliskan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Epidemiology of Japanese Encephalitis in the Philippines: A Systematic Review
- (2015) Anna Lena Lopez et al. PLoS Neglected Tropical Diseases
- MOV10 Is a 5′ to 3′ RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3′ UTRs
- (2014) Lea H. Gregersen et al. MOLECULAR CELL
- The dengue virus non-structural 1 protein: Risks and benefits
- (2014) Jaime Henrique Amorim et al. VIRUS RESEARCH
- The flavivirus NS1 protein: Molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker
- (2013) David A. Muller et al. ANTIVIRAL RESEARCH
- NS1' Colocalizes with NS1 and Can Substitute for NS1 in West Nile Virus Replication
- (2013) L. B. Young et al. JOURNAL OF VIROLOGY
- Targeting frameshifting in the human immunodeficiency virus
- (2012) Léa Brakier-Gingras et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1' formation and contributes to attenuation
- (2012) Q. Ye et al. JOURNAL OF GENERAL VIROLOGY
- Japanese encephalitis virus NS1′ protein depends on pseudoknot secondary structure and is cleaved by caspase during virus infection and cell apoptosis
- (2012) Jin Sun et al. MICROBES AND INFECTION
- Estimated global incidence of Japanese encephalitis:
- (2011) Grant Campbell et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Japanese encephalitis virus: from genome to infectome
- (2011) Salini Krishnan Unni et al. MICROBES AND INFECTION
- A diverse range of gene products are effectors of the type I interferon antiviral response
- (2011) John W. Schoggins et al. NATURE
- Methods in Mammalian Autophagy Research
- (2010) Noboru Mizushima et al. CELL
- Identification of Alpha Interferon-Induced Genes Associated with Antiviral Activity in Daudi Cells and Characterization of IFIT3 as a Novel Antiviral Gene
- (2010) H. Schmeisser et al. JOURNAL OF VIROLOGY
- NS1' of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness
- (2009) E. B. Melian et al. JOURNAL OF VIROLOGY
- Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
- (2009) Paul Saftig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A conserved predicted pseudoknot in the NS2A-encoding sequence of West Nile and Japanese encephalitis flaviviruses suggests NS1' may derive from ribosomal frameshifting
- (2009) Andrew E Firth et al. Virology Journal
- Ecology and Geographical Expansion of Japanese Encephalitis Virus
- (2008) Andrew F. van den Hurk et al. Annual Review of Entomology
- Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-
- (2008) J. M. Zimmerer et al. CLINICAL CANCER RESEARCH
- Cyclic changes in gene expression induced by Peg-interferon alfa-2b plus ribavirin in peripheral blood monocytes (PBMC) of hepatitis C patients during the first 10 weeks of treatment
- (2008) Milton W Taylor et al. Journal of Translational Medicine
- TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
- (2008) Mohammad Shahidul Makki et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More